BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 26168921)

  • 1. Clinicopathological features of recurrent papillary thyroid cancer.
    Zhu J; Wang X; Zhang X; Li P; Hou H
    Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective analysis of the risk factors and clinical indications of dissection of lymph node posterior to right recurrent laryngeal nerve in 283 cases of papillary thyroid carcinoma].
    Zhang P; Zhang B; Bu J; Liu Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):109-14. PubMed ID: 24796458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
    Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
    Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
    Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ; Cho JS; Yoon JH; Park MH
    World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
    Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
    Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
    Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.
    Barczyński M; Konturek A; Stopa M; Nowak W
    Langenbecks Arch Surg; 2014 Feb; 399(2):237-44. PubMed ID: 24213969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
    Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
    Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy.
    Zhang W; Jiao D; Liu B; Sun S
    Med Sci Monit; 2016 Apr; 22():1274-9. PubMed ID: 27084873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Results of Observation vs Prophylactic Selective Level VI Neck Dissection for Papillary Thyroid Carcinoma at a Cancer Center.
    Ywata de Carvalho A; Chulam TC; Kowalski LP
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):599-606. PubMed ID: 25997016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
    Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.